FOUNDATION FIGHTING BLINDNESS RETINAL DEGENERATION FUND sold 14.7% of their position (556K shares) of OPUS GENETICS, INC. on the open market
Open‑market sale worth $2.76M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/2/2026ACC: 0002042266-26-000002
→
DirectorOther
Since Oct 2024
-556K
Net shares
Net seller
$2.76M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
556K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−556K
Price / share
$4.96
Trade value
$2.76M
% of position
14.7%
9/30/2026
3.79M→3.24M
Total
Net shares
−556K
Net value
-$2.76M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2026 | S · Sale | −556K | $4.96 | $2.76M | 14.7% | 3.79M | 3.24M |
| Total | −556K | -$2.76M | ||||||
Derivative Transactions0
No derivative transactions reported